About three months ago, IGM Biosciences announced plans to stay afloat by focusing its resources on a clinical-stage autoimmune asset.
Now the company is shelving …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Neurocrine Biosciences’ newly-debuted campaign acknowledges the frustration that congenital adrenal hyperplasia (CAH) patients, families and endocrinologists often feel. The “What the C@H?!” theme is a
Nobody wins with the current medical malpractice system in the U.S. That’s the thesis of a new documentary — produced by a physician and directed
MDMA is a safe and effective treatment for post-traumatic stress disorder in a racially and ethnically diverse population, according to the results of a study